Brought to you by 
CVS aims to change health care delivery in $77bn acquisition of Aetna
11 Dec 2017
Executive Summary
In a move to streamline and improve health care delivery, retail pharmacy giant and pharmaceutical benefits manager (PBM) CVS Health Corp. signed a definite agreement to buy publicly traded insurance company Aetna Inc. CVS is spending $145 in cash and issuing 0.8378 in its shares for each Aetna share, which is valued at $206 (a 16% premium). The entire agreement is worth $77bn, including the assumption of Aetna's debt. Upon deal closing, CVS stockholders will own 78% of the combined entity, and Aetna the rest.
Deal Industry
- Pharmaceuticals
- Services
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CVS aims to change health care delivery in $77bn acquisition of Aetna
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice